Form 8-K - Current report:
SEC Accession No. 0001129928-26-000024
Filing Date
2026-04-06
Accepted
2026-04-06 09:24:53
Documents
12
Period of Report
2026-04-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K oncy-20260406.htm   iXBRL 8-K 29814
2 EX-99.1 oncolyticsfdascacmeetingpr.htm EX-99.1 13660
  Complete submission text file 0001129928-26-000024.txt   161918

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncy-20260406.xsd EX-101.SCH 1812
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncy-20260406_lab.xml EX-101.LAB 21597
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncy-20260406_pre.xml EX-101.PRE 12516
16 EXTRACTED XBRL INSTANCE DOCUMENT oncy-20260406_htm.xml XML 2808
Mailing Address SUITE 325, 4350 EXECUTIVE DRIVE SAN DIEGO CA 92121
Business Address SUITE 325, 4350 EXECUTIVE DRIVE SAN DIEGO CA 92121 4036707377
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 980541667 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38512 | Film No.: 26839742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)